Skip to main content
United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
359.58
-0.58 (-0.16%)
Dec 20, 2024, 4:00 PM EST - Market closed

United Therapeutics Revenue

United Therapeutics had revenue of $748.90M in the quarter ending September 30, 2024, with 22.89% growth. This brings the company's revenue in the last twelve months to $2.76B, up 25.04% year-over-year. In the year 2023, United Therapeutics had annual revenue of $2.33B with 20.20% growth.

Revenue (ttm)
$2.76B
Revenue Growth
+25.04%
P/S Ratio
5.97
Revenue / Employee
$2,359,760
Employees
1,168
Market Cap
16.05B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.33B391.20M20.20%
Dec 31, 20221.94B250.80M14.88%
Dec 31, 20211.69B202.20M13.63%
Dec 31, 20201.48B34.50M2.38%
Dec 31, 20191.45B-179.00M-11.00%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molina Healthcare 37.54B
Baxter International 15.06B
Viatris 15.05B
Quest Diagnostics 9.54B
ICON Public Limited Company 8.31B
Moderna 5.08B
Hologic 4.03B
Align Technology 3.96B
Revenue Rankings

UTHR News

More News